Patent · US Active

Thienopyrimidinedione derivatives as TRPA1 modulators

US8987278B2 · kind B2 · utility

1Cited by

2References

29Claims

0Family size

Assignee

Glenmark Pharmaceuticals S.A. · CH

Inventors

Sukeerthi Kumar · Navi Mumbai, IN
Abraham Thomas · Jamkhed, IN
Nayan Taterao Waghmare · Pune, IN
Sanjay Margal · Navi Mumbai, IN
Neelima Khairatkar-Joshi · Thane, IN
Indranil Mukhopadhyay · Navi Mumbai, IN

Key dates

Filing date	Jun 25, 2013
Grant date	Mar 24, 2015
Priority date	—
Expiry date	Jun 25, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is related to novel thienopyrimidinedione derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.